PubMed

Modeling the effect of levothyroxine therapy on bone mass density in postmenopausal women: a different approach leads to new inference.

Mohammadi B, Haghpanah V, Tavangar SM, Larijani B.

Theor Biol Med Model. 2007 Jun 9;4:23.PMID: 17559682 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.PMID: 8996984 [PubMed - indexed for MEDLINE]Related articles

Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.

Mazokopakis EE, Starakis IK, Papadomanolaki MG, Batistakis AG, Papadakis JA.

Curr Med Res Opin. 2006 Jul;22(7):1369-73.PMID: 16834835 [PubMed - indexed for MEDLINE]Related articles

Bone changes in pre- and postmenopausal women with thyroid cancer on levothyroxine therapy: evolution of axial and appendicular bone mass.

Jódar E, Begoña López M, García L, Rigopoulou D, Martínez G, Hawkins F.

Osteoporos Int. 1998;8(4):311-6.PMID: 10024900 [PubMed - indexed for MEDLINE]Related articles

Lack of deleterious effect on bone mineral density of long-term thyroxine suppressive therapy for differentiated thyroid carcinoma.

Reverter JL, Holgado S, Alonso N, Salinas I, Granada ML, Sanmartí A.

Endocr Relat Cancer. 2005 Dec;12(4):973-81.PMID: 16322336 [PubMed - indexed for MEDLINE]Related articlesFree article

[Bone mineral density in patients on long-term therapy with levothyroxine]

Korsić M, Cvijetić S, Dekanić-Ozegović D, Bolanća S, Kozić B.

Lijec Vjesn. 1998 May;120(5):103-5. Croatian. PMID: 9748785 [PubMed - indexed for MEDLINE]Related articles

Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.

Sijanovic S, Karner I.

Medscape Womens Health. 2001 Oct;6(5):3.PMID: 11698925 [PubMed - indexed for MEDLINE]Related articlesFree article

Global skeletal uptake of technetium-99m methylene diphosphonate in female patients receiving suppressive doses of L-thyroxine for differentiated thyroid cancer.

Frusciante V, Carnevale V, Scillitani A, Zingrillo M, Dicembrino F, Giannatempo GM, Ghiggi MR, Minisola S.

Eur J Nucl Med. 1998 Feb;25(2):139-43.PMID: 9473261 [PubMed - indexed for MEDLINE]Related articles

[Evaluation of bone density in women after thyroid cancer surgery and treatment with suppressive doses of L-thyroxine]

Jurecka-Tuleja B, August R, Kukulska A, Bartnikowa W, Deja R, Czernik E, Handkiewicz-Junak D.

Wiad Lek. 2001;54 Suppl 1:378-82. Polish. PMID: 12182053 [PubMed - indexed for MEDLINE]Related articles

Bone mineral density in premenopausal women receiving levothyroxine suppressive therapy.

Nuzzo V, Lupoli G, Esposito Del Puente A, Rampone E, Carpinelli A, Del Puente AE, Oriente P.

Gynecol Endocrinol. 1998 Oct;12(5):333-7.PMID: 9859026 [PubMed - indexed for MEDLINE]Related articles

Bone density is not reduced during the short-term administration of levothyroxine to postmenopausal women with subclinical hypothyroidism: a randomized, prospective study.

Ross DS.

Am J Med. 1993 Oct;95(4):385-8.PMID: 8213870 [PubMed - indexed for MEDLINE]Related articles

Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism.

Affinito P, Sorrentino C, Farace MJ, di Carlo C, Moccia G, Canciello P, Palomba S, Nappi C.

Acta Obstet Gynecol Scand. 1996 Oct;75(9):843-8.PMID: 8931510 [PubMed - indexed for MEDLINE]Related articles

Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.

Panico A, Lupoli GA, Fonderico F, Marciello F, Martinelli A, Assante R, Lupoli G.

Thyroid. 2009 May;19(5):437-42.PMID: 19415993 [PubMed - indexed for MEDLINE]Related articles

[The risk factors and bone mineral density in women on long-term levothyroxine treatment]

López Alvarez MB, Hawkins F, Rigopoulou D, Martínez G, Jodar E, Estenoz J, Ortuño B, Arnaiz F.

Med Clin (Barc). 1999 Jan 30;112(3):85-9. Spanish. PMID: 10074614 [PubMed - indexed for MEDLINE]Related articles

The long term effect of levothyroxine on bone mineral density in patients with well differentiated thyroid carcinoma after treatment.

Eftekhari M, Asadollahi A, Beiki D, Izadyar S, Gholamrezanezhad A, Assadi M, Fard-Esfahani A, Fallahi B, Takavar A, Saghari M.

Hell J Nucl Med. 2008 Sep-Dec;11(3):160-3.PMID: 19081859 [PubMed - indexed for MEDLINE]Related articles

Osteodensitometry in healthy postmenopausal women.

[No authors listed]

Prescrire Int. 2008 Apr;17(94):68-72.PMID: 18536138 [PubMed - indexed for MEDLINE]Related articles

Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma.

Görres G, Kaim A, Otte A, Götze M, Müller-Brand J.

Eur J Nucl Med. 1996 Jun;23(6):690-2.PMID: 8662104 [PubMed - indexed for MEDLINE]Related articles

[The influence of thyrotoxicosis and thyroxine therapy on the risk of osteoporosis]

Zatońska K, Bolanowski M.

Pol Merkur Lekarski. 2000 May;8(47):356-9. Review. Polish. PMID: 10944962 [PubMed - indexed for MEDLINE]Related articles

Effectiveness and safety of vitamin D in relation to bone health.

Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V.

Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Review.PMID: 18088161 [PubMed - indexed for MEDLINE]Related articles

L-thyroxin treatment and post-menopausal osteoporosis: relevance of the risk profile present in clinical history.

La Vignera S, Vicari E, Tumino S, Ciotta L, Condorelli R, Vicari LO, Calogero AE.

Minerva Ginecol. 2008 Dec;60(6):475-84.PMID: 18981975 [PubMed - indexed for MEDLINE]Related articles